Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hiroyuki Ohbayashi, Yasuo Sato, Mari Kiuchi, Atsushi Nagazumi, Takumi Kanzo & Takazumi Kimura. (2022) Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan. Expert Review of Gastroenterology & Hepatology 16:8, pages 809-817.
Read now
Read now
Natalia Świątoniowska-Lonc, Wojciech Tański, Jacek Polański, Beata Jankowska-Polańska & Grzegorz Mazur. (2021) Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Review. Diabetes, Metabolic Syndrome and Obesity 14, pages 2701-2715.
Read now
Read now
Roberta Roberti, Caterina Palleria, Valentina Nesci, Martina Tallarico, Carlo Di Bonaventura, Emanuele Cerulli Irelli, Alessandra Morano, Giovambattista De Sarro, Emilio Russo & Rita Citraro. (2020) Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 983-995.
Read now
Read now
Bartosz Uchmanowicz, Anna Chudiak, Izabella Uchmanowicz, Joanna Rosińczuk & Erika Sivarajan Froelicher. (2018) Factors influencing adherence to treatment in older adults with hypertension. Clinical Interventions in Aging 13, pages 2425-2441.
Read now
Read now
Christian Leporini, Rosanna Piro, Francesco Ursini, Francesca Maida, Caterina Palleria, Franco Arturi, Maria Pavia, Giovambattista De Sarro & Emilio Russo. (2016) Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis. Expert Opinion on Drug Safety 15:sup2, pages 17-34.
Read now
Read now
Edoardo Ferlazzo, Emilio Russo, Laura Mumoli, Chiara Sueri, Sara Gasparini, Caterina Palleria, Angelo Labate, Antonio Gambardella, Giovambattista De Sarro & Umberto Aguglia. (2015) Profile of brivaracetam and its potential in the treatment of epilepsy. Neuropsychiatric Disease and Treatment 11, pages 2967-2973.
Read now
Read now
Laura Mumoli, Caterina Palleria, Sara Gasparini, Rita Citraro, Angelo Labate, Edoardo Ferlazzo, Antonio Gambardella, Giovambattista De Sarro & Emilio Russo. (2015) Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures. Drug Design, Development and Therapy 9, pages 5719-5725.
Read now
Read now
Articles from other publishers (76)
Antonio Ballesteros-Sánchez, José-María Sánchez-González, Giovanni Roberto Tedesco, Carlos Rocha-De-Lossada, Gianluca Murano, Antonio Spinelli & Davide Borroni. (2023) Assessing the Effects of 0.3% Carboxymethylcellulose Tear Substitute Treatment on Symptoms and Signs of Dry Eye Disease in Elderly Population: A Prospective Longitudinal Study. Journal of Clinical Medicine 12:23, pages 7364.
Crossref
Crossref
Jette A. van Lint, Marlieke Sonnenberg, Harald E. Vonkeman, Bart J. F. van den Bemt, Eugene P. van Puijenbroek & Naomi T. Jessurun. (2023) Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective. Drug Safety 46:10, pages 1039-1047.
Crossref
Crossref
Piotr Merks, Urszula Religioni, Miłosz Jaguszewski, Agnieszka Barańska, Agnieszka Neumann-Podczaska, Justyna Kaźmierczak, Eliza Blicharska, Katarina Fehir Šola & Regis Vaillancourt. (2023) Patient satisfaction survey of the “Healthy Heart” pharmaceutical care service – evaluation of pharmacy labelling with pharmaceutical pictograms. BMC Health Services Research 23:1.
Crossref
Crossref
Leslie M Coons & Jennifer Loucks. (2023) Role and impact of a clinical pharmacist in an ambulatory reproductive endocrinology and infertility clinic. American Journal of Health-System Pharmacy 80:18, pages 1206-1212.
Crossref
Crossref
Sarah Zaij, Kelly Pereira Maia, Géraldine Leguelinel-Blache, Clarisse Roux-Marson, Jean Marie Kinowski & Hélène Richard. (2023) Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review. BMC Health Services Research 23:1.
Crossref
Crossref
Su Golder, Karen O'Connor, Yunwen Wang & Graciela Gonzalez Hernandez. (2023) The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review. JMIR Research Protocols 12, pages e47068.
Crossref
Crossref
Daniela R Junqueira, Liliane Zorzela, Susan Golder, Yoon Loke, Joel J Gagnier, Steven A Julious, Tianjing Li, Evan Mayo-Wilson, Ba Pham, Rachel Phillips, Pasqualina Santaguida, Roberta W Scherer, Peter C Gøtzsche, David Moher, John P A Ioannidis & Sunita Vohra. (2023) CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. BMJ, pages e073725.
Crossref
Crossref
Daniela R. Junqueira, Liliane Zorzela, Susan Golder, Yoon Loke, Joel J. Gagnier, Steven A. Julious, Tianjing Li, Evan Mayo-Wilson, Ba Pham, Rachel Phillips, Pasqualina Santaguida, Roberta W. Scherer, Peter C. Gøtzsche, David Moher, John P.A. Ioannidis, Sunita Vohra, Stephen Evans, Ann Fonfa, Thomas A. Lang, Elizabeth Loder & Laura Weeks. (2023) CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials. Journal of Clinical Epidemiology.
Crossref
Crossref
Clara M.A. de Bruijn, Gabriëlla A.C. Hamming, Catherijne A.J. Knibbe, Ellen Tromp, Marc A. Benninga & Arine M. Vlieger. (2023) Teenagers’ and parental individual needs for side effects information and the influence of nocebo effect education. Patient Education and Counseling 108, pages 107587.
Crossref
Crossref
Warisara Srisuriyachanchai, Anthony R. Cox, Sirinya Kampichit & Narumol Jarernsiripornkul. (2023) Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey. International Journal of Environmental Research and Public Health 20:4, pages 3725.
Crossref
Crossref
Maria Kamusheva, Silvia Vandeva, Konstantin Mitov, Alexina Parvanova, Marina Pesheva, Nikolay Ganov, Yanitsa Rusenova, Lyubomir Marinov, Violeta Getova, Atanaska Elenkova & Guenka Petrova. (2023) Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria. Pharmaceutics 15:2, pages 438.
Crossref
Crossref
Victor Sung, Sanjay Gandhi, Victor Abler, Brian Davis, Debra Irwin, Karen Anderson & Ravi Iver. (2023) Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine. Journal of Health Economics and Outcomes Research, pages 15-24.
Crossref
Crossref
Yadeta Babu Bayane & Birbirsa Sefera Senbeta. (2023) Pattern of anti-epileptic medications nonadherence and associated factors at ambulatory clinic of Jimma Medical Center, Southwestern Ethiopia: A prospective observational study. SAGE Open Medicine 11, pages 205031212311608.
Crossref
Crossref
Oriana Awwad, Suha AlMuhaissen, Ayat Al-Nashwan & Salahdein AbuRuz. (2022) Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale. PLOS ONE 17:10, pages e0275778.
Crossref
Crossref
Henryka Homętowska, Natalia Świątoniowska-Lonc, Jakub Klekowski, Mariusz Chabowski & Beata Jankowska-Polańska. (2022) Treatment Adherence in Patients with Obstructive Pulmonary Diseases. International Journal of Environmental Research and Public Health 19:18, pages 11573.
Crossref
Crossref
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci & Silvana Galderisi. (2022) Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature. Frontiers in Psychiatry 13.
Crossref
Crossref
Nedal Awad Alnawaiseh & Ruba Yousef AL-Oroud. (2022) Knowledge, Attitude and Practices of Pharmacovigilance and Adverse Drug Reaction Reporting Among Pharmacists Working at Alkarak Governorate, Jordan. Biomedical and Pharmacology Journal 15:2, pages 967-978.
Crossref
Crossref
Edward C.Y. Lau, Ilsa Wojt, Yun-Hee Jeon, Sarah N. Hilmer & Edwin C.K. Tan. (2022) Prevalence and Risk Factors for Drug-Related Problems in People With Dementia Living in the Community: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association 23:6, pages 980-991.e10.
Crossref
Crossref
Kadesha A. James, Amanda C. Everall, Lauren Cadel, Lisa M. McCarthy, Aisha Lofters, Alison Thompson & Sara J.T. Guilcher. (2022) Exploring medication self-management in community-dwelling adults with chronic medication experience: A concept mapping study. Research in Social and Administrative Pharmacy 18:5, pages 2854-2866.
Crossref
Crossref
Qais Alefan, Shenzhen Yao, Jeffrey G. Taylor, Lisa M. Lix, Dean Eurich, Niteesh Choudhry & David F. Blackburn. (2022) Factors associated with early nonpersistence among patients experiencing side effects from a new medication. Journal of the American Pharmacists Association 62:3, pages 717-726.e5.
Crossref
Crossref
Victoria R Cornelius & Rachel Phillips. (2022) Improving the analysis of adverse event data in randomized controlled trials. Journal of Clinical Epidemiology 144, pages 185-192.
Crossref
Crossref
Sophie H. Bots, Michelle M. Schreuder, Jeanine E. Roeters van Lennep, Sarah Watson, Eugène van Puijenbroek, N. Charlotte Onland-Moret & Hester M. den Ruijter. (2022) Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors. JAMA Network Open 5:4, pages e228224.
Crossref
Crossref
Robyn Brown, Caryl James Bateman & Maxine Gossell-Williams. (2022) Influence of Jamaican Cultural and Religious Beliefs on Adherence to Pharmacotherapy for Non-Communicable Diseases: A Pharmacovigilance Perspective. Frontiers in Pharmacology 13.
Crossref
Crossref
Yuvaraj Krishnamoorthy, Sathish Rajaa, Tanveer Rehman & Mahalakshmi Thulasingam. (2022) Patient and provider’s perspective on barriers and facilitators for medication adherence among adult patients with cardiovascular diseases and diabetes mellitus in India: a qualitative evidence synthesis. BMJ Open 12:3, pages e055226.
Crossref
Crossref
Stella Maris Nanyonga, Freddy Eric Kitutu, Joan Kalyango, Mulindwa Frank & Ronald Kiguba. (2022) High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors. JAIDS Journal of Acquired Immune Deficiency Syndromes 89:2, pages 215-221.
Crossref
Crossref
Noel Patson, Mavuto Mukaka, Ingrid Peterson, Titus Divala, Lawrence Kazembe, Don Mathanga, Miriam K. Laufer & Tobias Chirwa. (2022) Effect of adverse events on non-adherence and study non-completion in malaria chemoprevention during pregnancy trial: A nested case control study. PLOS ONE 17:1, pages e0262797.
Crossref
Crossref
Juan Tamargo, Ricardo Caballero & Eva Delpón. (2022) Sex-related differences in the pharmacological treatment of heart failure. Pharmacology & Therapeutics 229, pages 107891.
Crossref
Crossref
Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero & Juan de Dios Luna. (2021) The impact of PIPs on mortality and readmissions in older adults: a retrospective cohort study. European Journal of Clinical Pharmacology 78:1, pages 139-145.
Crossref
Crossref
Urška Nabergoj Makovec, Igor Locatelli & Mitja Kos. (2021) Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial. BMC Health Services Research 21:1.
Crossref
Crossref
Sophie Heleen Bots, N Charlotte Onland-Moret, Igor I Tulevski, Pim van der Harst, Maarten J M Cramer, Folkert W Asselbergs, G Aernout Somsen & Hester M den Ruijter. (2021) Heart failure medication dosage and survival in women and men seen at outpatient clinics. Heart 107:21, pages 1748-1755.
Crossref
Crossref
Martina Ambrož, Sieta T. de Vries, Klaas Hoogenberg & Petra Denig. (2021) Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives. Frontiers in Pharmacology 12.
Crossref
Crossref
Iwona Bonikowska, Katarzyna Szwamel & Izabella Uchmanowicz. (2021) Analysis of the Impact of Disease Acceptance, Demographic, and Clinical Variables on Adherence to Treatment Recommendations in Elderly Type 2 Diabetes Mellitus Patients. International Journal of Environmental Research and Public Health 18:16, pages 8658.
Crossref
Crossref
Folgerdiena M. de Vries, Julia C. Stingl & Monique M.B. Breteler. (2021) Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland Study. British Journal of Clinical Pharmacology 87:7, pages 2732-2756.
Crossref
Crossref
Pepijn W. A. Thomas, Rachel L. West, Maurice G. V. M. Russel, Jeroen M. Jansen, Leanne J. Kosse, Naomi T. Jessurun, Tessa E. H. Römkens & Frank Hoentjen. (2020) Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system. Pharmacoepidemiology and Drug Safety 30:4, pages 520-524.
Crossref
Crossref
Natalia Świątoniowska-Lonc, Jacek Polański, Grzegorz Mazur & Beata Jankowska-Polańska. (2021) Impact of Beliefs about Medicines on the Level of Intentional Non-Adherence to the Recommendations of Elderly Patients with Hypertension. International Journal of Environmental Research and Public Health 18:6, pages 2825.
Crossref
Crossref
Samuel K. Peasah, Jesse Fishman, Derek Ems, Michelle Vu, Tuong-Vi T. Huynh & Silky Beaty. (2020) Association Between Adverse Events and Discontinuation of Antiepileptic Drugs Among Drug-Naïve Adults with Epilepsy. Drugs - Real World Outcomes 8:1, pages 5-14.
Crossref
Crossref
Kieran Murray, Sean Quinn, Matthew Turk, Anna O’Rourke, Eamonn Molloy, Lorraine O’Neill, Ann Barbara Mongey, Ursula Fearon & Douglas J Veale. (2021) COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology 60:2, pages 902-906.
Crossref
Crossref
Sandip Sarkar, Nirupama Kasturi & Narayan Bardoloi. (2021) Minimizing topical medication in cataract surgery. TNOA Journal of Ophthalmic Science and Research 59:4, pages 338.
Crossref
Crossref
Kevin Yap, Eskinder Eshetu Ali & Lita Chew. 2021. Design and Quality Considerations for Developing Mobile Apps for Medication Management. Design and Quality Considerations for Developing Mobile Apps for Medication Management
1
31
.
Marios Spanakis, Marianna Roubedaki, Ioannis Tzanakis, Michail Zografakis-Sfakianakis, Evridiki Patelarou & Athina Patelarou. (2020) Impact of Adverse Drug Reactions in Patients with End Stage Renal Disease in Greece. International Journal of Environmental Research and Public Health 17:23, pages 9101.
Crossref
Crossref
Noel Patson, Mavuto Mukaka, Kennedy N. Otwombe, Lawrence Kazembe, Don P. Mathanga, Victor Mwapasa, Alinune N. Kabaghe, Marinus J. C. Eijkemans, Miriam K. Laufer & Tobias Chirwa. (2020) Systematic review of statistical methods for safety data in malaria chemoprevention in pregnancy trials. Malaria Journal 19:1.
Crossref
Crossref
Sunil Shrestha, Sabina Sharma, Ramesh Bhasima, Puskar Kunwor, Baburam Adhikari & Binaya Sapkota. (2020) Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Medical Education 20:1.
Crossref
Crossref
Carmelo Scarpignato, Michio Hongo, Justin C. Y. Wu, Christian Lottrup, Adriana Lazarescu, Ellen Stein & Richard H. Hunt. (2020) Pharmacologic treatment of GERD: Where we are now, and where are we going?. Annals of the New York Academy of Sciences 1482:1, pages 193-212.
Crossref
Crossref
Jette A. van Lint, Naomi T. Jessurun, Renske C. F. Hebing, Frank Hoentjen, Sander W. Tas, Harald E. Vonkeman, Martijn B. A. van Doorn, Annemieke Sobels, Phyllis I. Spuls, Eugene P. van Puijenbroek, Michael T. Nurmohamed & Bart J. F. van den Bemt. (2020) Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases. Drug Safety 43:9, pages 917-925.
Crossref
Crossref
Corine Ekhart, Tjalling de Vries & Florence van Hunsel. (2020) Psychiatric adverse drug reactions in the paediatric population. Archives of Disease in Childhood 105:8, pages 749-755.
Crossref
Crossref
Katja S. Just, Harald Dormann, Marlen Schurig, Miriam Böhme, Jochen Fracowiak, Michael Steffens, Catharina Scholl, Thomas Seufferlein, Ingo Gräff, Matthias Schwab & Julia C. Stingl. (2020) Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study. Journal of Clinical Medicine 9:6, pages 1801.
Crossref
Crossref
Su Golder, Karen O’Connor, Sean Hennessy, Robert Gross & Graciela Gonzalez-Hernandez. (2020) Assessment of Beliefs and Attitudes About Statins Posted on Twitter. JAMA Network Open 3:6, pages e208953.
Crossref
Crossref
Jyoti Kumar, Manjula Gudhoor & Madiwalayya Shivakantayya Ganachari. (2020) Parallel Assessment of Chemotherapy Adherence and Supportive Therapy Adherence on Occurrence and Minimization of Adverse Drug Reactions Among Cancer Patients: A Clinical-Based Observational Study. Journal of Pharmacy Technology 36:2, pages 72-77.
Crossref
Crossref
Yu.V. Lukina, N.P. Kutishenko, S.Yu. Martsevich, R.N. Shepel & O.M. Drapkina. (2020) Methodological recommendations: "Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations". Profilakticheskaya meditsina 23:3, pages 42.
Crossref
Crossref
Charles D. Ciccone. 2020. Guccione's Geriatric Physical Therapy. Guccione's Geriatric Physical Therapy
102
136
.
Lisa B. E. Shields, Paula Fowler, Diane M. Siemens, Douglas J. Lorenz, Kenneth C. Wilson, Steven T. Hester & Joshua T. Honaker. (2019) Standardized warfarin monitoring decreases adverse drug reactions. BMC Family Practice 20:1.
Crossref
Crossref
Sarah Watson, Ola Caster, Paula A Rochon & Hester den Ruijter. (2019) Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine 17, pages 100188.
Crossref
Crossref
Carla Pires, Pedro Joel Rosa, Marina Vigário & Afonso Cavaco. (2019) Validation of a new tool for evaluating subjects’ satisfaction with medicine package leaflets: a cross-sectional descriptive study. Sao Paulo Medical Journal 137:5, pages 454-462.
Crossref
Crossref
Alison E. Fohner, Dilrini K. Ranatunga, Khanh K. Thai, Brian L. Lawson, Neil Risch, Akinyemi Oni-Orisan, Aline T. Jelalian, Allan E. Rettie, Vincent X. Liu & Catherine A. Schaefer. (2019) Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. Pharmacogenetics and Genomics 29:8, pages 192-199.
Crossref
Crossref
Md. Akter Hossain & Md. Shah Amran. (2019) A Cross-Sectional Pilot Study on Pharmacovigilance to Improve the Drug Safety in Bangladesh. Biomedical & Pharmacology Journal 12:3, pages 1039-1049.
Crossref
Crossref
Sara Gasparini, Edoardo Ferlazzo, Chiara Sueri, Vittoria Cianci, Michele Ascoli, Salvatore M. Cavalli, Ettore Beghi, Vincenzo Belcastro, Amedeo Bianchi, Paolo Benna, Roberto Cantello, Domenico Consoli, Fabrizio A. De Falco, Giancarlo Di Gennaro, Antonio Gambardella, Gian Luigi Gigli, Alfonso Iudice, Angelo Labate, Roberto Michelucci, Maurizio Paciaroni, Pasquale Palumbo, Alberto Primavera, Ferdinando Sartucci, Pasquale Striano, Flavio Villani, Emilio Russo, Giovambattista De Sarro & Umberto Aguglia. (2019) Hypertension, seizures, and epilepsy: a review on pathophysiology and management. Neurological Sciences 40:9, pages 1775-1783.
Crossref
Crossref
Maryam Eghbali-Zarch, Reza Tavakkoli-Moghaddam, Fatemeh Esfahanian, Amir Azaron & Mohammad Mehdi Sepehri. (2019) A Markov decision process for modeling adverse drug reactions in medication treatment of type 2 diabetes. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 233:8, pages 793-811.
Crossref
Crossref
Marijke Coomans, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin van den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmström, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld & Martin J.B. Taphoorn. (2019) The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. European Journal of Cancer 116, pages 190-198.
Crossref
Crossref
Bernadine O'Donovan, Ruth M. Rodgers, Anthony R. Cox & Janet Krska. (2019) Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines. Pharmacoepidemiology and Drug Safety 28:7, pages 1023-1031.
Crossref
Crossref
Sophie H. BotsHester M. den Ruijter. (2019) Recommended Heart Failure Medications and Adverse Drug Reactions in Women. Circulation 139:12, pages 1469-1471.
Crossref
Crossref
Sophie H. Bots, Floor Groepenhoff, Anouk L.M. Eikendal, Cara Tannenbaum, Paula A. Rochon, Vera Regitz-Zagrosek, Virginia M. Miller, Danielle Day, Folkert W. Asselbergs & Hester M. den Ruijter. (2019) Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women. JACC: Heart Failure 7:3, pages 258-266.
Crossref
Crossref
Ashley Smaje, Maryse Weston‐Clark, Ranjana Raj, Mine Orlu, Daniel Davis & Mark Rawle. (2018) Factors associated with medication adherence in older patients: A systematic review. AGING MEDICINE 1:3, pages 254-266.
Crossref
Crossref
Yu. V. Lukina, N. A. Dmitrieva, N. P. Kutishenko, N. V. Kiseleva & S. Yu. Martsevich. (2018) The relationship and interinfluence of aspects of therapy safety and compliance in patients with cardiovascular diseases (by the data from outpatient registry “PROFILE”). Cardiovascular Therapy and Prevention 17:5, pages 72-78.
Crossref
Crossref
Shota Hori, Shuhei Fujimoto, Sho Sugita, Motohide Kobayashi & Kanako Komukai. (2018) The Effects of Intervention for the Health Literacy of Patients: A Systematic Review of Randomized Controlled Trials患者のヘルスリテラシーに対する介入の効果：ランダム化比較試験のシステマティックレビュー. An Official Journal of the Japan Primary Care Association 41:3, pages 100-109.
Crossref
Crossref
Victor W. Sung, Sanjay K. Gandhi, Victor Abler, Brian Davis, Debra E. Irwin, Karen E. Anderson & Ravi G. Iyer. (2018) Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine. Journal of Health Economics and Outcomes Research 6:1, pages 15-24.
Crossref
Crossref
Mario Ulises Pérez-Zepeda, Antonio Cherubini, Carmen García-Peña, Elisa Zengarini & Luis Miguel Gutiérrez-Robledo. 2018. Aging Research - Methodological Issues. Aging Research - Methodological Issues
115
127
.
Sabine E. M. de Hoon, Karin Hek, Liset van Dijk & Robert A. Verheij. (2017) Adverse events recording in electronic health record systems in primary care. BMC Medical Informatics and Decision Making 17:1.
Crossref
Crossref
Jan Furon, Mathieu Guerriaud, Odile Chambin & Yves Michiels. (2017) La pharmacovigilance à l’officine, de la définition à la mise en œuvre. Actualités Pharmaceutiques 56:571, pages 24-27.
Crossref
Crossref
Derbew Fikadu Berhe, Katja Taxis, Flora M. Haaijer-Ruskamp, Afework Mulugeta, Yewondwossen Tadesse Mengistu, Johannes G. M. Burgerhof & Peter G. M. Mol. (2017) Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients. British Journal of Clinical Pharmacology 83:9, pages 2107-2117.
Crossref
Crossref
Maria Vittoria Pacchiana, Enrica Capelletto, Simona Carnio, Cesare Gridelli, Antonio Rossi, Domenico Galetta, Elisabetta Sara Montagna, Paola Bordi, Anna Ceribelli, Diego Cortinovis, Vieri Scotti, Olga Martelli, Giuseppe Valmadre, Alessandro Del Conte, Annamaria Miccianza, Raffaella Morena, Francesco Rosetti, Massimo Di Maio, Luca Ostacoli & Silvia Novello. (2017) Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non–Small-cell Lung Cancer: A Multicenter Italian Survey. Clinical Lung Cancer 18:4, pages 381-387.
Crossref
Crossref
Angela Frances Yap, Thiru Thirumoorthy & Yu Heng Kwan. (2016) Systematic review of the barriers affecting medication adherence in older adults. Geriatrics & Gerontology International 16:10, pages 1093-1101.
Crossref
Crossref
Caterina Palleria, Christian Leporini, Francesca Maida, Elena Succurro, Giovambattista De Sarro, Franco Arturi & Emilio Russo. (2016) Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes. Frontiers in Neuroendocrinology 42, pages 76-92.
Crossref
Crossref
Angela Frances Yap, Thiru Thirumoorthy & Yu Heng Kwan. (2016) Medication adherence in the elderly. Journal of Clinical Gerontology and Geriatrics 7:2, pages 64-67.
Crossref
Crossref
Alfredo José Pardo Cabello, Esperanza Del Pozo Gavilán, Francisco Javier Gómez Jiménez, Carmen Mota Rodríguez, Juan de Dios Luna Del Castillo & Emilio Puche Cañas. (2016) Drug-related mortality among inpatients: a retrospective observational study. European Journal of Clinical Pharmacology 72:6, pages 731-736.
Crossref
Crossref
Lia Santulli, Antonietta Coppola, Simona Balestrini & Salvatore Striano. (2016) The challenges of treating epilepsy with 25 antiepileptic drugs. Pharmacological Research 107, pages 211-219.
Crossref
Crossref
Bart De Spiegeleer, Evelien Wynendaele, Nathalie Bracke, Lieselotte Veryser, Lien Taevernier, Agnes Degroote & Sofie Stalmans. (2016) Regulatory development of geriatric medicines: To GIP or not to GIP?. Ageing Research Reviews 27, pages 23-36.
Crossref
Crossref